CHIARAVALLOTI, AGOSTINO
 Distribuzione geografica
Continente #
NA - Nord America 24.047
EU - Europa 2.246
AS - Asia 868
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 8
SA - Sud America 8
AF - Africa 3
Totale 27.191
Nazione #
US - Stati Uniti d'America 24.036
SG - Singapore 539
DE - Germania 525
IT - Italia 456
IE - Irlanda 311
UA - Ucraina 238
CN - Cina 217
RU - Federazione Russa 173
GB - Regno Unito 155
FR - Francia 130
SE - Svezia 111
FI - Finlandia 63
KR - Corea 56
PL - Polonia 18
CZ - Repubblica Ceca 17
VN - Vietnam 13
IN - India 12
CA - Canada 11
EU - Europa 9
JP - Giappone 8
CH - Svizzera 7
KG - Kirghizistan 7
NO - Norvegia 7
NL - Olanda 6
RO - Romania 6
AT - Austria 5
AU - Australia 5
ES - Italia 5
BE - Belgio 4
BR - Brasile 3
CL - Cile 3
NZ - Nuova Zelanda 3
TR - Turchia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BG - Bulgaria 2
HK - Hong Kong 2
IR - Iran 2
PT - Portogallo 2
TH - Thailandia 2
AL - Albania 1
AO - Angola 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
CO - Colombia 1
GR - Grecia 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
KZ - Kazakistan 1
MA - Marocco 1
MK - Macedonia 1
MN - Mongolia 1
SA - Arabia Saudita 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 27.191
Città #
Wilmington 7.370
Houston 5.842
Woodbridge 5.707
Fairfield 755
Chandler 612
Singapore 471
Ann Arbor 450
Ashburn 371
Seattle 327
Dublin 296
Cambridge 232
Medford 215
Jacksonville 212
Rome 187
Dearborn 184
New York 180
Santa Clara 131
Beijing 117
Lawrence 99
Moscow 98
Boardman 90
San Diego 49
Menlo Park 43
Creede 26
Redwood City 24
Munich 22
Milan 21
Kunming 18
Kraków 17
London 16
Nanjing 16
Norwalk 16
Palo Alto 16
Brno 15
Washington 14
Phoenix 13
Helsinki 12
Mülheim 12
Dong Ket 10
Toronto 10
Detroit 9
Verona 8
Hefei 7
Kilburn 7
Mountain View 7
Pune 7
Engelhard 6
Napoli 6
Nuremberg 6
Saint Petersburg 6
Salerno 6
Chiswick 5
Council Bluffs 5
Guangzhou 5
Islington 5
Keele 5
Padova 5
Redmond 5
San Francisco 5
Seoul 5
University Park 5
Acton 4
Atlanta 4
Augusta 4
Brussels 4
Chengdu 4
Falls Church 4
Hebei 4
Jinan 4
Los Angeles 4
Monmouth Junction 4
Prescot 4
Slough 4
Tokyo 4
Vienna 4
Bologna 3
Chester 3
Chongqing 3
Colorado Springs 3
Hanoi 3
Iasi 3
Lappeenranta 3
Lugano 3
Mezzomerico 3
New Bedfont 3
North Hollywood 3
Nürnberg 3
Portugalete 3
Shaoxing 3
São Paulo 3
Turin 3
Walton on Thames 3
Acireale 2
Adelaide 2
Anzio 2
Bangalore 2
Bangkok 2
Baotou 2
Buffalo 2
Capalbio 2
Totale 24.564
Nome #
Usefulness of 18F Florbetaben in diagnosis of Alzheimer's disease and other types of dementia 472
Studio del metabolismo cerebrale in corso di stimolo olfattivo nella Sindrome da Sensibilità Chimica Multipla: dalla (dis)percezione olfattoria al correlato neurobiologico 440
18F FDOPA uptake in brain metastasis of breast cancer 435
111In-pentetreotide SPECT/CT in pulmonary carcinoid 431
Autonomic Function Tests and MIBG in Parkinson's Disease: Correlation to Disease Duration and Motor Symptoms 427
A case of intracranial meningioma detected by 18F-choline PET/CT and examined by PET/MRI fusion imaging 423
18F-choline PET/CT pitfalls in image interpretation: An update on 300 examined patients with prostate cancer 413
Comparison of 18F FDOPA PET, DSC-MRI and spectroscopy in a patient with brain metastatic lesions from lung cancer 412
Cortical activity during olfactory stimulation in multiple chemical sensitivity: a 18F-FDG PET/CT study 408
WIDEN: A tool for medical image management in multicenter clinical trials 408
Cardiac sympathetic denervation is not related to nigrostriatal degeneration in Parkinson's disease 407
Decoupled association between 18F-FDG and 18F-FDOPA uptake in a carcinoid of the thymus 399
Detection of local recurrence of prostate cancer after radical prostatectomy: Is there a role for early 18F-FCH PET/CT? 398
Factors affecting intrapatient liver and mediastinal blood pool 18F-FDG standardized uptake value changes during ABVD chemotherapy in Hodgkin's lymphoma 394
Is cerebral glucose metabolism affected by chemotherapy in patients with Hodgkin's lymphoma? 392
Reply to comments by Laffon et al.: Liver SUV versus stage in Hodgkin's lymphoma: the total amount of uptake may play a role in the inverse relationship 391
Different patterns of nigrostriatal degeneration in tremor type versus the akinetic-rigid and mixed types of Parkinson's disease at the early stages: molecular imaging with 123I-FP-CIT SPECT 390
Molecular imaging of brain tumors with 18F-DOPA PET and PET/CT 389
Chronic obstructive pulmonary disease (COPD) patients with osteoporotic vertebral compression fractures (OVCFs): improvement of pulmonary function after percutaneous vertebroplasty (VTP) 387
18F-FDG PET/MR in herpes simplex virus encephalitis: A case study 387
Involvement of Subcortical Brain Structures During Olfactory Stimulation in Multiple Chemical Sensitivity 381
Thalamic ¹²³I FP-CIT uptake in a patient with clinical diagnosis of Parkinson's disease and depression 380
Evaluation of recurrent disease in the re-staging of colorectal cancer by 18F-FDG PET/CT: Use of CEA and CA 19-9 in patient selection. 372
Factors affecting 18F FDOPA standardized uptake value in patients with primary brain tumors after treatment 369
Cerebellar metabolic involvement and its correlations with clinical parameters in vestibular neuritis. 368
Different patterns of cardiac sympathetic denervation in tremor-type compared to akinetic-rigid-type Parkinson's disease: molecular imaging with ¹²³I-MIBG. 363
Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer’s disease 352
Low-dose CT and contrast-medium CT in hybrid PET/CT systems for oncologic patients 345
Reverse perfusion pattern in myocardial spect with 99mTc-sestaMIBI. 343
Cortical 18F FDG-PET changes during olfactory stimulation in normal subjects 339
Cortical 18F FDG-PET changes during olfactory stimulation in normal subjects 339
Functional correlates of t-Tau, p-Tau and Aβ1-42 amyloid cerebrospinal fluid levels in Alzheimer's disease: A 18F-FDG PET/CT study 339
PICASO: a personalised integrated care platform 339
Does 123I-MIBG scintigraphy really assist the diagnosis of Parkinson's disease? 332
PET Probe-guided surgery in patients with breast cancer: Proposal for a methodological approach 332
Brain metabolic changes in hodgkin disease patients following diagnosis and during the disease course: An 18F-FDG PET/CT study 331
Cortical metabolic changes in vestibular neurutis detected by 18F-FDG PET/CT 328
When cognitive decline and depression coexist in the elderly: CSF biomarkers analysis can differentiate Alzheimer's disease from late-life depression 328
The Role of PET [18F]FDOPA in Evaluating Low-grade Glioma 324
Cortical Involvement in Unilateral Vestibular Deficit: Early Metabolic Changes 318
Il coinvolgimento corticale nel deficit vestibolare acuto 313
Does123I-MIBG scintigraphy really assist the diagnosis of Parkinson's disease? 313
Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study 312
Early and phasic cortical metabolic changes in vesibular neuritis onset 306
Transient parkinsonism after unilateral midbrain stroke: a compensatory intervention from the healthy side? 304
Cortical metabolic arrangement during olfactory processing: Proposal for a 18F FDG PET/CT methodological approach 304
cerebellar metabolic involvement and its correlations with clinical parameters in vestibular neuritis: “tor vergata” university experience 303
New acquisition of cerbral metabolic neural pathways related to olfactory stimulation 302
Initial staging of hodgkin's disease: Role of contrast-enhanced 18F FDG PET/CT 299
Early cortical responses during vestibular neuritis 289
Do CSF levels of t-Tau, p-Tau and beta(1-42) amyloid correlate with dopaminergic system impairment in patients with a clinical diagnosis of Parkinson disease? A I-123-FP-CIT study in the early stages of the disease 288
Dopaminergic involvement in a drummer with focal dystonia: A case study 285
Cortico-subcortical metabolic correlates of olfactory processing in healthy reasting subjects 284
Metabolic and electrophysiological changes associated to clinical improvement in two severely traumatized subjects treated with EMDR-A pilot study 284
Cortical metabolic changes in vestibular neuritis detected by 18F-FDG PET/CT 274
18F-DOPA PET/CT and MRI findings in a patient with multiple meningiomas 270
Quantitative analysis of basal and interim PET/CT images for predicting tumor recurrence in patients with Hodgkin's lymphoma 261
Functional correlates of TSH, fT3 and fT4 in Alzheimer disease: A F-18 FDG PET/CT study 258
PET/CT with 18F–choline: Physiological whole bio-distribution in male and female subjects and diagnostic pitfalls on 1000 prostate cancer patients: 18F–choline PET/CT bio-distribution and pitfalls. A southern Italian experience 256
Is cerebral glucose metabolism related to blood-brain barrier dysfunction and intrathecal IgG synthesis in Alzheimer disease? A 18F-FDG PET/CT study 255
Sleep apnoeas may represent a reversible risk factor for amyloid-β pathology 251
Correction to: Predictive and prognostic value of 18F-DOPA PET/CT in patients affected by recurrent medullary carcinoma of the thyroid (Annals of Nuclear Medicine, (2018), 32, 1, (7-15), 10.1007/s12149-017-1213-0) 249
Does fatigue in Parkinson’s disease correlate with autonomic nervous system dysfunction? 247
Predictive and prognostic value of 18F-DOPA PET/CT in patients affected by recurrent medullary carcinoma of the thyroid 247
Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer's disease patients: A CSF and FDG PET study 246
A patient with a benign and a malignant primary pulmonary meningioma: An evaluation with 18F fluorodeoxyglucose positron emission tomography/computed tomography and computed tomography with iodinated contrast 245
Aspects of cerebral plasticity related to clinical features in acute vestibular neuritis: A “starting point” review from neuroimaging studies|La plasticità cerebrale correlata alle caratteristiche cliniche nella neuronite vestibolare acuta: Una revisione della letteratura di neuroimaging 244
Coupled Imaging with [ 18 F]FBB and [ 18 F]FDG in AD Subjects Show a Selective Association Between Amyloid Burden and Cortical Dysfunction in the Brain 242
Ageing effect on 18 F-DOPA and 123 I-MIBG uptake: A cross-sectional study 241
A rare case of primary uterine non-hodgkins's lymphoma with involvement of right ovary: Staging with 18F FDG PET/CT and iodinated contrast CT 234
18F-labeled radiopharmaceuticals for the molecular neuroimaging of amyloid plaques in Alzheimer's disease 231
Overall survival and progression-free survival in patients with primary brain tumors after treatment: is the outcome of [18F] FDOPA PET a prognostic factor in these patients? 223
Evaluation of the usefulness of FDG-PET/CT for nodal staging of breast cancer 221
Early cortical metabolic rearrangement related to clinical data in idiopathic sudden sensorineural hearing loss 210
18F-dopa pet/ct physiological distribution and pitfalls: Experience in 215 patients 201
Impact of awake breast cancer surgery on postoperative lymphocyte responses 194
Rearfoot Transcutaneous Oximetry is a Useful Tool to Highlight Ischemia of the Heel 187
Prostate cancer and inflammation: A new molecular imaging challenge in the era of personalized medicine 186
PET/CT with 18F-choline after radical prostatectomy in patients with PSA ≤2 ng/ml. Can PSA velocity and PSA doubling time help in patient selection? 183
Comparison between Early-Onset and Late-Onset Alzheimer's Disease Patients with Amnestic Presentation: CSF and 18F-FDG PET Study 177
Brain glucose consumption abnormalities in neuro-Behçet's disease: a preliminary 18F-FDG PET/CT study 176
Cerebral metabolic changes related to clinical parameters in idiopathic anosmic patients during olfactory stimulation: a pilot investigation 175
Evaluation of Task-Related Brain Activity: Is There a Role for 18F FDG-PET Imaging? 155
Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer’s disease 149
Molecular imaging in pediatric brain tumors 135
Early chemotherapy intensification with escalated beacopp in patients with advanced-stage hodgkin lymphoma with a positive interim positron emission tomography/computed tomography scan after two abvd cycles: Long-term results of the GITIL/FIL HD 0607 trial 130
Long-term follow-up of endovascular treatment of renal artery aneurysms with covered stent deployment 105
18F-FDG PET, cognitive functioning, and CSF biomarkers in patients with obstructive sleep apnoea before and after continuous positive airway pressure treatment 66
[18F] FBB cortical uptake is not related to the age of onset of Alzheimer’s disease 62
10-Year clinical experience with 18F-choline PET/CT: an Italian multicenter retrospective assessment of 3343 patients 55
The brain metabolic correlates of the main indices of neuropsychological assessment in Alzheimer’s disease 53
Brain metabolic patterns in patients with suspected non-Alzheimer’s pathophysiology (SNAP) and Alzheimer’s disease (AD): is [18F] FDG a specific biomarker in these patients? 52
Awake breast cancer surgery: strategy in the beginning of COVID-19 emergency 50
18f-fdopa pet/ct suv-derived indices and volumetric parameters correlation in patients with primary brain tumors 44
Hearing and cognitive impairment: a functional evaluation of associative brain areas in patients affected by Alzheimer's disease 44
MGMT promoter methylation and IDH1 mutations do not affect [18F]FDOPA uptake in primary brain tumors 44
Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study 38
18F-FDG and amyloid PET imaging in Alzheimer's disease 36
Nocturnal hypoxia and sleep fragmentation may drive neurodegenerative processes: the compared effects of obstructive sleep apnea syndrome and periodic limb movement disorder on Alzheimer's disease biomarkers 35
Medical imaging in the diagnosis of schistosomiasis: a review 32
Totale 26.980
Categoria #
all - tutte 63.607
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.607


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.477 0 0 523 696 681 826 683 677 710 622 506 553
2020/20214.684 563 553 481 616 509 476 549 448 111 155 156 67
2021/20221.049 52 78 133 69 19 74 38 65 62 74 72 313
2022/20231.557 157 139 104 151 110 295 134 185 131 36 69 46
2023/2024834 70 23 52 20 83 236 21 30 13 30 22 234
2024/20251.013 100 645 268 0 0 0 0 0 0 0 0 0
Totale 27.665